US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

ADC Therapeutics SA

1.23

+0.02001.65%

Post-market: 1.250.0181+1.47%17:34 EDT

Volume:266.95K

Turnover:329.04K

Market Cap:121.87M

PE:-0.76

High:1.26

Open:1.21

Low:1.20

Close:1.21

Loading ...

Overview Company News Filings

Jefferies Reaffirms Their Buy Rating on ADC Therapeutics (ADCT)

ADC Therapeutics Price Target Maintained With a $8.00/Share by HC Wainwright & Co.

ADC Therapeutics Makes Grants to New Employees Under Inducement Plan

Update: ADC Shares Rise After Company Completes Enrollment in Late-Stage Zynlonta Combination Trial

MT Newswires Live

ADC Completes Enrollment in Late-Stage Zynlonta Combination Trial

MT Newswires Live

BRIEF-Adc Therapeutics Announces Completion Of Enrollment Of Phase 3 Confirmatory Clinical Trial Of Zynlonta In Combination With Rituximab In 2L+ Diffuse Large B-Cell Lymphoma

ADC Therapeutics completes enrollment in LOTIS-5 trial

ADC Therapeutics Announces Completion of Enrollment of Phase 3 Confirmatory Clinical Trial of Zynlonta® in Combination With Rituximab in 2L+ Diffuse Large B-Cell Lymphoma

THOMSON REUTERS

ADC Therapeutics Announces Completion of Enrollment of Phase 3 Confirmatory Clinical Trial of ZYNLONTA® in Combination with Rituximab in 2L+ Diffuse Large B-Cell Lymphoma

ADC Therapeutics Price Target Maintained With a $10.00/Share by Guggenheim

ADC Therapeutics falls -8.9%

BRIEF-ADC Therapeutics Announces Positive Initial Data From Lotis-7 Clinical Trial Evaluating Zynlonta® In Combination With Bispecific

ADC Therapeutics announces data from LOTIS-7 Phase 1b open-label clinical trial

ADC Therapeutics Announces Positive Initial Data From Lotis-7 Clinical Trial Evaluating Zynlonta® in Combination With Bispecific Antibody in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma

THOMSON REUTERS

ADC Therapeutics Sa - Zynlonta Plus Glofitamab Shows 94% Orr and 72% Cr Rate

THOMSON REUTERS

ADC Therapeutics Sa - No Dose-Limiting Toxicities or High-Grade Crs/Icans Observed

THOMSON REUTERS

ADC Therapeutics Announces Positive Initial Data from LOTIS-7 Clinical Trial Evaluating ZYNLONTA® in Combination with Bispecific Antibody in Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma

ADC Therapeutics: Updated data from Phase 2 Zynlonta study published in Lancet

ADC Therapeutics Announces The Lancet Haematology Publication of Data from Investigator-Initiated Trial Evaluating ZYNLONTA® in Combination with Rituximab to Treat Relapsed/Refractory Follicular Lymphoma

BRIEF-ADC Therapeutics to Provide Initial Data Update on LOTIS-7 Clinical Trial

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/ADCT/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ADCT","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ADCT\",,,,,undefined,":{"symbol":"ADCT","market":"US","secType":"STK","nameCN":"ADC Therapeutics SA","latestPrice":1.23,"timestamp":1745265600000,"preClose":1.21,"halted":0,"volume":266949,"hourTrading":{"tag":"盘后","latestPrice":1.2481,"preClose":1.23,"latestTime":"17:34 EDT","volume":1218,"amount":1498.1362242,"timestamp":1745271285685},"delay":0,"floatShares":73042346,"shares":99083838,"eps":-1.624599,"marketStatus":"Post-Mkt","change":0.02,"latestTime":"04-21 18:24:29 EDT","open":1.21,"high":1.26,"low":1.2,"amount":329035.35774239997,"amplitude":0.049587,"askPrice":1.35,"askSize":100,"bidPrice":1.05,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-1.624599,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1745280000000},"marketStatusCode":4,"adr":0,"listingDate":1589515200000,"exchange":"NYSE","adjPreClose":1.21,"preHourTrading":{"tag":"盘前","latestPrice":1.2187,"preClose":1.21,"latestTime":"09:21 EDT","volume":111,"amount":134.4057153,"timestamp":1745241699118},"postHourTrading":{"tag":"盘后","latestPrice":1.2481,"preClose":1.23,"latestTime":"17:34 EDT","volume":1218,"amount":1498.1362242,"timestamp":1745271285685},"volumeRatio":1.167024,"impliedVol":3.3329,"impliedVolPercentile":0.992},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ADCT\",,,,,undefined,":{"symbol":"ADCT","floatShares":73042346,"roa":"-24.13%","roe":"-705.53%","lyrEps":-1.624599,"volumeRatio":1.167024,"shares":99083838,"dividePrice":0,"high":1.26,"amplitude":0.049587,"preClose":1.21,"low":1.2,"week52Low":1.05,"pbRate":"-0.60","psRate":"1.72","week52High":5.17,"institutionHeld":0,"latestPrice":1.23,"eps":-1.624599,"divideRate":0,"volume":266949,"delay":0,"ttmEps":-1.624599,"open":1.21,"prevYearClose":1.99,"prevWeekClose":1.21,"prevMonthClose":1.41,"prevQuarterClose":1.41,"fiveDayClose":1.22,"twentyDayClose":1.61,"sixtyDayClose":1.76},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ADCT\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2505834886","title":"Jefferies Reaffirms Their Buy Rating on ADC Therapeutics (ADCT)","url":"https://stock-news.laohu8.com/highlight/detail?id=2505834886","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505834886?lang=en_us&edition=fundamental","pubTime":"2025-01-24 17:58","pubTimestamp":1737712680,"startTime":"0","endTime":"0","summary":"In a report released on January 21, Kelly Shi from Jefferies maintained a Buy rating on ADC Therapeutics (ADCT – Research Report), with a price tar...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/jefferies-reaffirms-their-buy-rating-on-adc-therapeutics-adct?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/jefferies-reaffirms-their-buy-rating-on-adc-therapeutics-adct?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ADCT","ADC"],"gpt_icon":0},{"id":"2501806302","title":"ADC Therapeutics Price Target Maintained With a $8.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2501806302","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501806302?lang=en_us&edition=fundamental","pubTime":"2025-01-06 19:42","pubTimestamp":1736163720,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ADCT/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  January 06, 2025 06:42 ET (11:42 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","ADC","ADCT"],"gpt_icon":0},{"id":"2500290256","title":"ADC Therapeutics Makes Grants to New Employees Under Inducement Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2500290256","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2500290256?lang=en_us&edition=fundamental","pubTime":"2025-01-03 05:05","pubTimestamp":1735851900,"startTime":"0","endTime":"0","summary":"LAUSANNE, Switzerland, Jan. 2, 2025 /PRNewswire/ -- ADC Therapeutics SA , a commercial-stage global leader and pioneer in the field of antibody drug conjugates , today announced that the Company has made grants of options to purchase an aggregate of 20,000 of the Company's common shares to two new employees on January 2, 2025 .The Grants were offered as material inducement to the employees' employment. The grants were approved by the Compensation Committee of the Company's Board of Directors pursuant to the Company's Inducement Plan to motivate and reward the recipients to perform at the highest levels and contribute significantly to the success of the Company. The Grants were made in reliance on the employment inducement exemption under the NYSE's Listed Company Manual Rule 303A.08.The Company is issuing this press release pursuant to Rule 303A.08. The Grants shall vest and become exercisable 25% on the first anniversary of the grant date, and 1/48th of the aggregate number of shares ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/adc-therapeutics-makes-grants-employees-210500076.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/adc-therapeutics-makes-grants-employees-210500076.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LENZ","BK4080","BK4231","BK4139","ADC","BK4505","ADCT"],"gpt_icon":0},{"id":"2500892641","title":"Update: ADC Shares Rise After Company Completes Enrollment in Late-Stage Zynlonta Combination Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2500892641","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2500892641?lang=en_us&edition=fundamental","pubTime":"2025-01-01 03:15","pubTimestamp":1735672550,"startTime":"0","endTime":"0","summary":"ADC Therapeutics  gained as much as 4.2% in intraday trading Tuesday after the company said it had completed patient enrollment in its phase 3 confirmatory trial of Zynlonta in combination with rituximab in patients with relapsed or refractory diffuse large B-cell lymphoma.\"We anticipate sharing topline results of the primary endpoint analysis by the end of 2025 once the pre-specified number of events is reached and potentially submitting our supplemental BLA to the US Food and Drug Administration in the first quarter of 2026,\" said Chief Medical Officer Mohamed Zaki in a statement late Monday.The stock was up 0.8% in recent trading.Price: 1.91, Change: +0.01, Percent Change: +0.53","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","ADC","BK4505","SSI","ADCT","BK4080","BK4231"],"gpt_icon":0},{"id":"2495502609","title":"ADC Completes Enrollment in Late-Stage Zynlonta Combination Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2495502609","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2495502609?lang=en_us&edition=fundamental","pubTime":"2024-12-31 07:02","pubTimestamp":1735599750,"startTime":"0","endTime":"0","summary":"ADC Therapeutics  said late Monday it has completed patient enrollment in its phase 3 confirmatory trial of Zynlonta in combination with rituximab in patients with relapsed or refractory diffuse large B-cell lymphoma.\"We anticipate sharing topline results of the primary endpoint analysis by the end of 2025 once the pre-specified number of events is reached and potentially submitting our supplemental BLA to the US Food and Drug Administration in the first quarter of 2026,\" said Chief Medical Officer Mohamed Zaki.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4231","SSI","BK4505","BK4080","BK4139","ADCT","ADC"],"gpt_icon":0},{"id":"2495066315","title":"BRIEF-Adc Therapeutics Announces Completion Of Enrollment Of Phase 3 Confirmatory Clinical Trial Of Zynlonta In Combination With Rituximab In 2L+ Diffuse Large B-Cell Lymphoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2495066315","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2495066315?lang=en_us&edition=fundamental","pubTime":"2024-12-31 05:51","pubTimestamp":1735595474,"startTime":"0","endTime":"0","summary":"BRIEF-Adc Therapeutics Announces Completion Of Enrollment Of Phase 3 Confirmatory Clinical Trial Of Zynlonta In Combination With Rituximab In 2L+ Diffuse Large B-Cell LymphomaDec 30 (Reuters) - ADC Th","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241230:nTUA58SV53:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ADCT","BK4139","BK4505"],"gpt_icon":0},{"id":"2495505918","title":"ADC Therapeutics completes enrollment in LOTIS-5 trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2495505918","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2495505918?lang=en_us&edition=fundamental","pubTime":"2024-12-31 05:35","pubTimestamp":1735594530,"startTime":"0","endTime":"0","summary":"ADC Therapeutics (ADCT) announced the completion of enrollment in LOTIS-5, the Phase 3 confirmatory trial evaluating Zynlonta in combination with r...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/adc-therapeutics-completes-enrollment-in-lotis-5-trial?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/adc-therapeutics-completes-enrollment-in-lotis-5-trial?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4080","BK4505","ADCT","BK4231","LENZ","BK4139","ADC"],"gpt_icon":0},{"id":"2495350505","title":"ADC Therapeutics Announces Completion of Enrollment of Phase 3 Confirmatory Clinical Trial of Zynlonta® in Combination With Rituximab in 2L+ Diffuse Large B-Cell Lymphoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2495350505","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2495350505?lang=en_us&edition=fundamental","pubTime":"2024-12-31 05:30","pubTimestamp":1735594202,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241230:nTUA58SV53:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ADCT","BK4139","BK4505"],"gpt_icon":0},{"id":"2495550529","title":"ADC Therapeutics Announces Completion of Enrollment of Phase 3 Confirmatory Clinical Trial of ZYNLONTA® in Combination with Rituximab in 2L+ Diffuse Large B-Cell Lymphoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2495550529","media":"PR Newswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2495550529?lang=en_us&edition=fundamental","pubTime":"2024-12-31 05:30","pubTimestamp":1735594200,"startTime":"0","endTime":"0","summary":"LAUSANNE, Switzerland, Dec. 30, 2024 /PRNewswire/ -- ADC Therapeutics SA , a commercial-stage global leader and pioneer in the field of antibody drug conjugates , today announced the completion of enrollment in LOTIS-5,the Phase 3 confirmatory trial evaluating ZYNLONTA in combination with rituximab  in patients with relapsed or refractory diffuse large B-cell lymphoma . ZYNLONTA previously received accelerated approval for the treatment of r/r DLBCL after two or more lines of systemic therapy from the FDA in 2021.The U.S. Food and Drug Administration  and the European Medicines Agency  have approved ZYNLONTA  for the treatment of adult patients with relapsed or refractory (r/r) large B-cell","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/adc-therapeutics-announces-completion-enrollment-213000821.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/adc-therapeutics-announces-completion-enrollment-213000821.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ADCT","BK4080","BK4139","BK4231","LENZ","BK4161","CR","BK4505","ADC","PBD"],"gpt_icon":0},{"id":"2490338152","title":"ADC Therapeutics Price Target Maintained With a $10.00/Share by Guggenheim","url":"https://stock-news.laohu8.com/highlight/detail?id=2490338152","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490338152?lang=en_us&edition=fundamental","pubTime":"2024-12-12 23:40","pubTimestamp":1734018000,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ADCT/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  December 12, 2024 10:40 ET (15:40 GMT)","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ADC","LENZ","ADCT"],"gpt_icon":0},{"id":"2490653708","title":"ADC Therapeutics falls -8.9%","url":"https://stock-news.laohu8.com/highlight/detail?id=2490653708","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490653708?lang=en_us&edition=fundamental","pubTime":"2024-12-11 22:50","pubTimestamp":1733928634,"startTime":"0","endTime":"0","summary":"ADC Therapeutics (ADCT) is down -8.9%, or -31c to $3.17. Published first on TheFly – the ultimate source for real-time, market-moving breaking fina...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/adc-therapeutics-falls-8-9?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/adc-therapeutics-falls-8-9?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ","BK4139","ADC","BK4505","ADCT","BK4080","BK4231"],"gpt_icon":0},{"id":"2490528618","title":"BRIEF-ADC Therapeutics Announces Positive Initial Data From Lotis-7 Clinical Trial Evaluating Zynlonta® In Combination With Bispecific","url":"https://stock-news.laohu8.com/highlight/detail?id=2490528618","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490528618?lang=en_us&edition=fundamental","pubTime":"2024-12-11 21:32","pubTimestamp":1733923955,"startTime":"0","endTime":"0","summary":"BRIEF-ADC Therapeutics Announces Positive Initial Data From Lotis-7 Clinical Trial Evaluating Zynlonta In Combination With Bispecific Dec 11 (Reuters) - ADC Therapeutics ADCT.N:ADC THERAPEUTICS ANNOUN","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241211:nTUA8TGNVN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4505","ADCT","BK4139"],"gpt_icon":0},{"id":"2490856436","title":"ADC Therapeutics announces data from LOTIS-7 Phase 1b open-label clinical trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2490856436","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490856436?lang=en_us&edition=fundamental","pubTime":"2024-12-11 20:35","pubTimestamp":1733920531,"startTime":"0","endTime":"0","summary":"ADC Therapeutics (ADCT) announced positive initial data from the LOTIS-7 Phase 1b open-label clinical trial evaluating the safety and efficacy of Z...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/adc-therapeutics-announces-data-from-lotis-7-phase-1b-open-label-clinical-trial?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/adc-therapeutics-announces-data-from-lotis-7-phase-1b-open-label-clinical-trial?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ADCT","ADC","BK4080","BK4505","BK4231","BK4139","LENZ"],"gpt_icon":0},{"id":"2490985650","title":"ADC Therapeutics Announces Positive Initial Data From Lotis-7 Clinical Trial Evaluating Zynlonta® in Combination With Bispecific Antibody in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2490985650","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490985650?lang=en_us&edition=fundamental","pubTime":"2024-12-11 20:30","pubTimestamp":1733920203,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241211:nTUA8TGNVN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4505","BK4139","ADCT"],"gpt_icon":0},{"id":"2490856504","title":"ADC Therapeutics Sa - Zynlonta Plus Glofitamab Shows 94% Orr and 72% Cr Rate","url":"https://stock-news.laohu8.com/highlight/detail?id=2490856504","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490856504?lang=en_us&edition=fundamental","pubTime":"2024-12-11 20:30","pubTimestamp":1733920203,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241211:nTUA8TGNVN:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4505","ADCT"],"gpt_icon":0},{"id":"2490565038","title":"ADC Therapeutics Sa - No Dose-Limiting Toxicities or High-Grade Crs/Icans Observed","url":"https://stock-news.laohu8.com/highlight/detail?id=2490565038","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490565038?lang=en_us&edition=fundamental","pubTime":"2024-12-11 20:30","pubTimestamp":1733920203,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241211:nTUA8TGNVN:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4505","ADCT","BK4139"],"gpt_icon":0},{"id":"2490854140","title":"ADC Therapeutics Announces Positive Initial Data from LOTIS-7 Clinical Trial Evaluating ZYNLONTA® in Combination with Bispecific Antibody in Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2490854140","media":"PR Newswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490854140?lang=en_us&edition=fundamental","pubTime":"2024-12-11 20:30","pubTimestamp":1733920200,"startTime":"0","endTime":"0","summary":"ZYNLONTA in combination with glofitamab demonstrated clinically meaningful benefit with 94% best ORR and 72% CR rate. Safety data show no dose-limiting toxicities , no high-grade cytokine release syndrome  or high-grade immune effector cell-associated neurotoxicity syndrome  across all patients. LAUSANNE, Switzerland, Dec. 11, 2024 /PRNewswire/ -- ADC Therapeutics SA , a commercial-stage global leader and pioneer in the field of antibody drug conjugates , today announced positive initial data from the LOTIS-7 Phase 1b open-label clinical trial evaluating the safety and efficacy of ZYNLONTA in combination with the bispecific antibody glofitamab  in patients with relapsed or refractory diffuse large B-cell lymphoma .\"We are excited by the strong initial results observed with ZYNLONTA plus glofitamab in second line plus patients with relapsed or refractory DLBCL,\" said Mohamed Zaki, MD, PhD, Chief Medical Officer of ADC Therapeutics. \"We believe these data support our hypothesis that comb","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/Et0V8U3X6l.Laaek.1Xhrg--~B/aD0yNTA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/b45d5be0d129d2f2b168ba1839a068c7","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/Et0V8U3X6l.Laaek.1Xhrg--~B/aD0yNTA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/b45d5be0d129d2f2b168ba1839a068c7"],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/adc-therapeutics-announces-positive-initial-123000966.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/adc-therapeutics-announces-positive-initial-123000966.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE00B19Z4B17.USD","BK4080","BK4139","BK4213","LENZ","ADC","BK4161","IE0031619046.USD","IE00B66KJ199.SGD","PR","BK4231","CR","CRS","IE00B7SZL793.SGD","ADCT","BK4505","BK4006"],"gpt_icon":0},{"id":"2490273937","title":"ADC Therapeutics: Updated data from Phase 2 Zynlonta study published in Lancet","url":"https://stock-news.laohu8.com/highlight/detail?id=2490273937","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490273937?lang=en_us&edition=fundamental","pubTime":"2024-12-09 21:23","pubTimestamp":1733750611,"startTime":"0","endTime":"0","summary":"ADC Therapeutics (ADCT) announced updated data from the investigator-initiated Phase 2 clinical trial evaluating ZYNLONTA in combination with ritux...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/adc-therapeutics-updated-data-from-phase-2-zynlonta-study-published-in-lancet?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/adc-therapeutics-updated-data-from-phase-2-zynlonta-study-published-in-lancet?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ","BK4080","BK4139","ADC","BK4231","BK4505","ADCT"],"gpt_icon":0},{"id":"2490152773","title":"ADC Therapeutics Announces The Lancet Haematology Publication of Data from Investigator-Initiated Trial Evaluating ZYNLONTA® in Combination with Rituximab to Treat Relapsed/Refractory Follicular Lymphoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2490152773","media":"PR Newswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490152773?lang=en_us&edition=fundamental","pubTime":"2024-12-09 20:30","pubTimestamp":1733747400,"startTime":"0","endTime":"0","summary":"Publication follows oral presentation at the American Society of Hematology  Annual Meeting. Combination in r/r follicular lymphoma shows best ORR of 97% and CR rate of 77% with 12-month PFS of 95%. Additional IIT data also presented at ASH on ZYNLONTA monotherapy in marginal zone lymphomashows ORR of 91% and 70% CR. LAUSANNE, Switzerland, Dec. 9, 2024 /PRNewswire/ --ADC Therapeutics SA , a commercial-stage global leader and pioneer in the field of antibody drug conjugates , today announced updated data from the investigator-initiated Phase 2 clinical trial evaluating ZYNLONTA in combination with rituximab to treat relapsed or refractory (r/r) follicular lymphoma  were published in the December issue of The Lancet Haematology, following an oral presentation of the data at the recent 66thAmerican Society of Hematology  Annual Meeting and Exposition.The most common treatment-emergent adverse events  were hyperglycemia  follow","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/Et0V8U3X6l.Laaek.1Xhrg--~B/aD0yNTA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/b45d5be0d129d2f2b168ba1839a068c7","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/Et0V8U3X6l.Laaek.1Xhrg--~B/aD0yNTA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/b45d5be0d129d2f2b168ba1839a068c7"],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/adc-therapeutics-announces-lancet-haematology-123000558.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/adc-therapeutics-announces-lancet-haematology-123000558.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4588","BK4585","PFS","ADC","BK4195","BK4138","BK4139","ASH","LU2463526074.USD","BK4161","BK4211","BK4094","AE","BK4505","BK4109","FL","PBD","CR","LENZ","BK4231","ADCT","BK4080"],"gpt_icon":0},{"id":"2489284880","title":"BRIEF-ADC Therapeutics to Provide Initial Data Update on LOTIS-7 Clinical Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2489284880","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2489284880?lang=en_us&edition=fundamental","pubTime":"2024-12-06 20:33","pubTimestamp":1733488418,"startTime":"0","endTime":"0","summary":"BRIEF-ADC Therapeutics to Provide Initial Data Update on LOTIS-7 Clinical TrialDec 6 (Reuters) - ADC Therapeutics SA ADCT.N:ADC THERAPEUTICS TO PROVIDE INITIAL DATA UPDATE ON LOTIS-7 CLINICAL TRIALSource text: ID:nPn9Lxw5KaFurther company coverage: ADCT.N ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241206:nTUAVKCZK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ADCT","BK4139","BK4505"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":2,"totalSize":61,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ADCT\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-03-27","symbol":"ADCT","fiscalQuarterEnding":"2024/12","expectedEps":-0.35,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1743048000000,"reportTimeType":"pre","actualEps":-0.29},{"market":"US","date":"2024-11-07","symbol":"ADCT","fiscalQuarterEnding":"2024/09","expectedEps":-0.36,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1730955600000,"reportTimeType":"pre","actualEps":-0.42},{"market":"US","date":"2024-08-06","symbol":"ADCT","fiscalQuarterEnding":"2024/06","expectedEps":-0.44,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1722916800000,"reportTimeType":"pre","actualEps":-0.38},{"market":"US","date":"2024-05-06","symbol":"ADCT","fiscalQuarterEnding":"2024/03","expectedEps":-0.56,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1714968000000,"reportTimeType":"pre","actualEps":-0.56},{"market":"US","date":"2024-03-13","symbol":"ADCT","fiscalQuarterEnding":"2023/12","expectedEps":-0.47,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1710302400000,"reportTimeType":"pre","actualEps":-1.03}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ADCT\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ADCT\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.5,"buy":0.5,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.5,"analysts":6,"updateTime":1731038400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ADCT\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ADCT","date":"2025-04-17","current":-0.728161,"percent":0.905237,"low":-30.997833,"twenty":-9.535072,"median":-2.32592,"eighty":-0.985973,"high":-0.211833,"avg":-5.272905,"sd":6.155005,"marketCap":114937252},"quantilePoints":[{"date":"2020-05-15","current":-17.536086,"twenty":-9.616954,"median":-0.000177,"eighty":-0.000177,"marketCap":2042673417},{"date":"2020-05-22","current":-20.877701,"twenty":-18.857355,"median":-10.428148,"eighty":-0.000177,"marketCap":2431918099},{"date":"2020-05-29","current":-22.436238,"twenty":-21.275146,"median":-17.743088,"eighty":-0.000177,"marketCap":2613462710},{"date":"2020-06-05","current":-21.221827,"twenty":-21.720306,"median":-19.727358,"eighty":-1.680174,"marketCap":2472003294},{"date":"2020-06-12","current":-24.48252,"twenty":-22.336656,"median":-21.221827,"eighty":-8.80576,"marketCap":2851821826},{"date":"2020-06-19","current":-25.199022,"twenty":-23.30697,"median":-21.389248,"eighty":-11.849736,"marketCap":2935282882},{"date":"2020-06-26","current":-26.200911,"twenty":-24.393868,"median":-21.768312,"eighty":-17.577486,"marketCap":3051986900},{"date":"2020-07-02","current":-30.997833,"twenty":-25.557273,"median":-22.254076,"eighty":-17.743088,"marketCap":3610751593},{"date":"2020-07-10","current":-26.352712,"twenty":-26.249487,"median":-22.440622,"eighty":-18.417326,"marketCap":3069669327},{"date":"2020-07-17","current":-29.753062,"twenty":-26.911341,"median":-23.432054,"eighty":-19.150707,"marketCap":3465755692},{"date":"2020-07-24","current":-29.54054,"twenty":-28.423282,"median":-24.078728,"eighty":-20.304008,"marketCap":3441000294},{"date":"2020-07-31","current":-28.235049,"twenty":-28.848326,"median":-24.48252,"eighty":-20.877701,"marketCap":3288931422},{"date":"2020-08-07","current":-29.224793,"twenty":-29.27337,"median":-25.642282,"eighty":-21.221827,"marketCap":3404220846},{"date":"2020-08-14","current":-24.002827,"twenty":-29.27337,"median":-25.727291,"eighty":-21.246115,"marketCap":2795945357},{"date":"2020-08-21","current":-12.705361,"twenty":-29.224793,"median":-25.378147,"eighty":-20.304008,"marketCap":3006838027},{"date":"2020-08-28","current":-13.700395,"twenty":-28.848326,"median":-24.470376,"eighty":-17.536086,"marketCap":3242321814},{"date":"2020-09-04","current":-11.038006,"twenty":-28.836182,"median":-24.036223,"eighty":-13.180467,"marketCap":2612243572},{"date":"2020-09-11","current":-11.557934,"twenty":-28.598157,"median":-23.596,"eighty":-12.625878,"marketCap":2735289155},{"date":"2020-09-18","current":-13.595812,"twenty":-28.456072,"median":-22.806633,"eighty":-12.292407,"marketCap":3217571266},{"date":"2020-09-25","current":-10.88536,"twenty":-28.425711,"median":-22.396769,"eighty":-12.012124,"marketCap":2576118310},{"date":"2020-10-02","current":-10.454224,"twenty":-28.389279,"median":-21.99905,"eighty":-11.634429,"marketCap":2474086227},{"date":"2020-10-09","current":-10.969642,"twenty":-28.264195,"median":-21.466135,"eighty":-11.291396,"marketCap":2596064431},{"date":"2020-10-16","current":-9.094467,"twenty":-27.963021,"median":-21.246115,"eighty":-10.880822,"marketCap":2152287575},{"date":"2020-10-23","current":-9.022315,"twenty":-27.501544,"median":-20.590854,"eighty":-10.812747,"marketCap":2135212088},{"date":"2020-10-30","current":-9.409314,"twenty":-27.155438,"median":-18.417326,"eighty":-10.696698,"marketCap":2226798793},{"date":"2020-11-06","current":-10.65886,"twenty":-26.947773,"median":-15.618241,"eighty":-10.523479,"marketCap":2522515190},{"date":"2020-11-13","current":-11.592266,"twenty":-26.464438,"median":-13.595812,"eighty":-10.632323,"marketCap":2615748437},{"date":"2020-11-20","current":-12.331832,"twenty":-26.308994,"median":-13.328378,"eighty":-10.658129,"marketCap":2782628530},{"date":"2020-11-27","current":-11.867453,"twenty":-26.276204,"median":-13.174491,"eighty":-10.680006,"marketCap":2677843356},{"date":"2020-12-04","current":-12.331832,"twenty":-26.254345,"median":-13.078277,"eighty":-10.696049,"marketCap":2782628530},{"date":"2020-12-11","current":-11.833055,"twenty":-26.220341,"median":-12.769705,"eighty":-10.707707,"marketCap":2670081491},{"date":"2020-12-18","current":-11.526909,"twenty":-26.146262,"median":-12.441907,"eighty":-10.723985,"marketCap":2601000894},{"date":"2020-12-24","current":-12.723974,"twenty":-26.100115,"median":-12.441907,"eighty":-10.751747,"marketCap":2871113789},{"date":"2020-12-31","current":-11.010933,"twenty":-26.055182,"median":-12.331832,"eighty":-10.788727,"marketCap":2484572922},{"date":"2021-01-08","current":-11.241402,"twenty":-25.89245,"median":-12.30097,"eighty":-10.74099,"marketCap":2536577416},{"date":"2021-01-15","current":-11.193244,"twenty":-25.71879,"median":-12.256155,"eighty":-10.74099,"marketCap":2525710805},{"date":"2021-01-22","current":-11.475311,"twenty":-25.684786,"median":-12.230255,"eighty":-10.784019,"marketCap":2589358097},{"date":"2021-01-29","current":-9.827627,"twenty":-25.557273,"median":-12.085078,"eighty":-10.730233,"marketCap":2217564773},{"date":"2021-02-05","current":-10.42272,"twenty":-25.199022,"median":-11.925931,"eighty":-10.694104,"marketCap":2351845034},{"date":"2021-02-12","current":-10.481197,"twenty":-24.48252,"median":-11.865086,"eighty":-10.540793,"marketCap":2365040204},{"date":"2021-02-19","current":-10.64287,"twenty":-24.472805,"median":-11.822736,"eighty":-10.545402,"marketCap":2401520969},{"date":"2021-02-26","current":-9.146539,"twenty":-24.164344,"median":-11.760818,"eighty":-10.475802,"marketCap":2063879850},{"date":"2021-03-05","current":-7.825639,"twenty":-24.073263,"median":-11.697181,"eighty":-10.427062,"marketCap":1765824242},{"date":"2021-03-12","current":-8.695919,"twenty":-24.016186,"median":-11.650743,"eighty":-10.337412,"marketCap":1962199421},{"date":"2021-03-19","current":-8.744074,"twenty":-23.793949,"median":-11.595706,"eighty":-10.111427,"marketCap":2153578034},{"date":"2021-03-26","current":-7.822006,"twenty":-23.508563,"median":-11.557934,"eighty":-9.980357,"marketCap":1926481811},{"date":"2021-04-01","current":-7.949725,"twenty":-23.439341,"median":-11.526909,"eighty":-9.766398,"marketCap":1957937707},{"date":"2021-04-09","current":-7.473115,"twenty":-23.056801,"median":-11.42698,"eighty":-9.494543,"marketCap":1840553511},{"date":"2021-04-16","current":-7.255058,"twenty":-22.589657,"median":-11.354744,"eighty":-9.404647,"marketCap":1786848323},{"date":"2021-04-23","current":-7.242598,"twenty":-22.439746,"median":-11.265481,"eighty":-9.176298,"marketCap":1783779455},{"date":"2021-04-30","current":-7.644445,"twenty":-22.388876,"median":-11.193244,"eighty":-9.059703,"marketCap":1882750444},{"date":"2021-05-07","current":-7.115899,"twenty":-22.295366,"median":-11.122033,"eighty":-8.882034,"marketCap":1809864832},{"date":"2021-05-14","current":-6.404007,"twenty":-22.10106,"median":-11.041891,"eighty":-8.724812,"marketCap":1628801627},{"date":"2021-05-21","current":-6.316529,"twenty":-21.860607,"median":-11.022972,"eighty":-8.581029,"marketCap":1606552335},{"date":"2021-05-28","current":-6.5307,"twenty":-21.624293,"median":-10.969642,"eighty":-8.364032,"marketCap":1661024740},{"date":"2021-06-04","current":-6.636713,"twenty":-21.478564,"median":-10.921497,"eighty":-8.204539,"marketCap":1687988214},{"date":"2021-06-11","current":-6.700063,"twenty":-21.392196,"median":-10.87763,"eighty":-8.015142,"marketCap":1704100828},{"date":"2021-06-18","current":-7.013799,"twenty":-21.32315,"median":-10.862668,"eighty":-7.846615,"marketCap":1783896635},{"date":"2021-06-25","current":-7.565853,"twenty":-21.2364,"median":-10.855893,"eighty":-7.68058,"marketCap":1924306563},{"date":"2021-07-02","current":-7.294351,"twenty":-21.084177,"median":-10.814044,"eighty":-7.589619,"marketCap":1855252500},{"date":"2021-07-09","current":-7.378818,"twenty":-20.762962,"median":-10.807561,"eighty":-7.53213,"marketCap":1876735987},{"date":"2021-07-16","current":-6.862965,"twenty":-20.073348,"median":-10.722423,"eighty":-7.453029,"marketCap":1745533266},{"date":"2021-07-23","current":-6.500962,"twenty":-19.004031,"median":-10.694467,"eighty":-7.384851,"marketCap":1653461182},{"date":"2021-07-30","current":-6.347111,"twenty":-18.282478,"median":-10.661185,"eighty":-7.309434,"marketCap":1614330546},{"date":"2021-08-06","current":-9.872651,"twenty":-17.701688,"median":-10.64287,"eighty":-7.309434,"marketCap":1978015279},{"date":"2021-08-13","current":-10.255609,"twenty":-16.768948,"median":-10.543674,"eighty":-7.346842,"marketCap":2054742016},{"date":"2021-08-20","current":-9.669684,"twenty":-13.693224,"median":-10.481197,"eighty":-7.352283,"marketCap":1937350109},{"date":"2021-08-27","current":-11.293424,"twenty":-13.650793,"median":-10.46771,"eighty":-7.359556,"marketCap":2262671474},{"date":"2021-09-03","current":-10.70367,"twenty":-13.580872,"median":-10.540793,"eighty":-7.384851,"marketCap":2144512299},{"date":"2021-09-10","current":-10.251779,"twenty":-13.52111,"median":-10.481197,"eighty":-7.408985,"marketCap":2053974749},{"date":"2021-09-17","current":-11.052161,"twenty":-13.45836,"median":-10.46771,"eighty":-7.435734,"marketCap":2214333629},{"date":"2021-09-24","current":-10.833875,"twenty":-13.198396,"median":-10.540793,"eighty":-7.438849,"marketCap":2170599389},{"date":"2021-10-01","current":-10.110085,"twenty":-13.180467,"median":-10.524755,"eighty":-7.448202,"marketCap":2025585856},{"date":"2021-10-08","current":-9.026315,"twenty":-13.168515,"median":-10.454224,"eighty":-7.472335,"marketCap":1808449191},{"date":"2021-10-15","current":-9.753934,"twenty":-13.135646,"median":-10.436428,"eighty":-7.473115,"marketCap":1954229991},{"date":"2021-10-22","current":-10.002857,"twenty":-13.078277,"median":-10.42794,"eighty":-7.481386,"marketCap":2004102370},{"date":"2021-10-29","current":-11.101946,"twenty":-13.061078,"median":-10.428044,"eighty":-7.526636,"marketCap":2224308105},{"date":"2021-11-05","current":-8.978957,"twenty":-12.834049,"median":-10.42272,"eighty":-7.554108,"marketCap":2258872162},{"date":"2021-11-12","current":-8.072824,"twenty":-12.723974,"median":-10.414231,"eighty":-7.565853,"marketCap":2030912586},{"date":"2021-11-19","current":-6.968379,"twenty":-12.705361,"median":-10.401133,"eighty":-7.554108,"marketCap":1753062867},{"date":"2021-11-26","current":-6.773118,"twenty":-12.69819,"median":-10.353923,"eighty":-7.479732,"marketCap":1703940265},{"date":"2021-12-03","current":-6.547347,"twenty":-12.583617,"median":-10.339859,"eighty":-7.438226,"marketCap":1647142256},{"date":"2021-12-10","current":-6.211742,"twenty":-12.46461,"median":-10.324541,"eighty":-7.354126,"marketCap":1562712783},{"date":"2021-12-17","current":-6.071398,"twenty":-12.395125,"median":-10.267318,"eighty":-7.293144,"marketCap":1527405913},{"date":"2021-12-23","current":-6.486328,"twenty":-12.352471,"median":-10.253694,"eighty":-7.250074,"marketCap":1631791443},{"date":"2021-12-31","current":-6.162927,"twenty":-12.331832,"median":-10.171358,"eighty":-7.105523,"marketCap":1550432133},{"date":"2022-01-07","current":-6.040889,"twenty":-12.3175,"median":-10.121011,"eighty":-7.020244,"marketCap":1519730506},{"date":"2022-01-14","current":-5.253743,"twenty":-12.299574,"median":-10.110085,"eighty":-6.950448,"marketCap":1321705016},{"date":"2022-01-21","current":-4.780845,"twenty":-12.287114,"median":-10.104599,"eighty":-6.910115,"marketCap":1202736214},{"date":"2022-01-28","current":-4.561176,"twenty":-12.268538,"median":-10.039178,"eighty":-6.845427,"marketCap":1147473286},{"date":"2022-02-04","current":-4.921189,"twenty":-12.253403,"median":-9.999027,"eighty":-6.800821,"marketCap":1238043084},{"date":"2022-02-11","current":-4.664908,"twenty":-12.241668,"median":-9.853579,"eighty":-6.776298,"marketCap":1173569669},{"date":"2022-02-18","current":-4.63745,"twenty":-12.20396,"median":-9.827627,"eighty":-6.705493,"marketCap":1166661803},{"date":"2022-02-25","current":-5.165265,"twenty":-12.16083,"median":-9.796669,"eighty":-6.699929,"marketCap":1299446337},{"date":"2022-03-04","current":-4.698153,"twenty":-12.130264,"median":-9.752019,"eighty":-6.643297,"marketCap":1080697249},{"date":"2022-03-11","current":-4.678132,"twenty":-12.058414,"median":-9.720992,"eighty":-6.550137,"marketCap":1076092005},{"date":"2022-03-18","current":-4.758372,"twenty":-12.012124,"median":-9.665854,"eighty":-6.518116,"marketCap":1094549297},{"date":"2022-03-25","current":-4.444486,"twenty":-11.956638,"median":-9.585433,"eighty":-6.483887,"marketCap":1022347448},{"date":"2022-04-01","current":-4.952046,"twenty":-11.921655,"median":-9.540274,"eighty":-6.413783,"marketCap":1139099373},{"date":"2022-04-08","current":-4.621465,"twenty":-11.897133,"median":-9.469884,"eighty":-6.348106,"marketCap":1063057001},{"date":"2022-04-14","current":-4.738337,"twenty":-11.867453,"median":-9.451949,"eighty":-6.33378,"marketCap":1089940668},{"date":"2022-04-22","current":-4.22076,"twenty":-11.862719,"median":-9.396921,"eighty":-6.301447,"marketCap":970884429},{"date":"2022-04-29","current":-3.930248,"twenty":-11.833055,"median":-9.359488,"eighty":-6.223946,"marketCap":904059314},{"date":"2022-05-06","current":-3.656433,"twenty":-11.812416,"median":-9.256858,"eighty":-6.181232,"marketCap":841074723},{"date":"2022-05-13","current":-2.908534,"twenty":-11.778017,"median":-9.146539,"eighty":-6.147606,"marketCap":567629425},{"date":"2022-05-20","current":-2.774717,"twenty":-11.760818,"median":-9.106345,"eighty":-6.098857,"marketCap":541513862},{"date":"2022-05-27","current":-2.908534,"twenty":-11.750499,"median":-9.084629,"eighty":-6.040889,"marketCap":567629425},{"date":"2022-06-03","current":-2.833754,"twenty":-11.720228,"median":-9.022315,"eighty":-5.907257,"marketCap":553035434},{"date":"2022-06-10","current":-2.625158,"twenty":-11.687894,"median":-8.959641,"eighty":-5.295236,"marketCap":512325881},{"date":"2022-06-17","current":-2.499214,"twenty":-11.659183,"median":-8.930575,"eighty":-5.114619,"marketCap":487746528},{"date":"2022-06-24","current":-3.105322,"twenty":-11.651867,"median":-8.88457,"eighty":-5.035294,"marketCap":606034663},{"date":"2022-07-01","current":-3.361147,"twenty":-11.644552,"median":-8.853868,"eighty":-4.979156,"marketCap":655961473},{"date":"2022-07-08","current":-4.057778,"twenty":-11.623913,"median":-8.75365,"eighty":-4.940669,"marketCap":791916017},{"date":"2022-07-15","current":-3.187973,"twenty":-11.596394,"median":-8.716575,"eighty":-4.916514,"marketCap":622164863},{"date":"2022-07-22","current":-2.896726,"twenty":-11.592266,"median":-8.673367,"eighty":-4.863223,"marketCap":565325110},{"date":"2022-07-29","current":-2.916405,"twenty":-11.578533,"median":-8.603044,"eighty":-4.834506,"marketCap":569165634},{"date":"2022-08-05","current":-3.266689,"twenty":-11.556014,"median":-8.464639,"eighty":-4.783286,"marketCap":637526959},{"date":"2022-08-12","current":-4.23153,"twenty":-11.542643,"median":-8.395183,"eighty":-4.759708,"marketCap":791147913},{"date":"2022-08-19","current":-3.459173,"twenty":-11.525533,"median":-8.255681,"eighty":-4.732722,"marketCap":646744216},{"date":"2022-08-26","current":-2.929204,"twenty":-11.509575,"median":-8.173063,"eighty":-4.684434,"marketCap":547658701},{"date":"2022-09-02","current":-2.641625,"twenty":-11.483364,"median":-8.056523,"eighty":-4.669511,"marketCap":493891367},{"date":"2022-09-09","current":-2.6379,"twenty":-11.455979,"median":-8.007179,"eighty":-4.639426,"marketCap":493194896},{"date":"2022-09-16","current":-2.244566,"twenty":-11.377028,"median":-7.912344,"eighty":-4.562396,"marketCap":419655300},{"date":"2022-09-23","current":-2.090653,"twenty":-11.370438,"median":-7.851859,"eighty":-4.517953,"marketCap":390878937},{"date":"2022-09-30","current":-2.060725,"twenty":-11.366962,"median":-7.79397,"eighty":-4.436472,"marketCap":385283533},{"date":"2022-10-07","current":-2.035073,"twenty":-11.354091,"median":-7.644366,"eighty":-4.262834,"marketCap":380487472},{"date":"2022-10-14","current":-2.009421,"twenty":-11.339866,"median":-7.603949,"eighty":-4.11858,"marketCap":375691412},{"date":"2022-10-21","current":-2.043624,"twenty":-11.292651,"median":-7.573998,"eighty":-3.940266,"marketCap":382086159},{"date":"2022-10-28","current":-1.958117,"twenty":-11.279928,"median":-7.526636,"eighty":-3.826688,"marketCap":366099290},{"date":"2022-11-04","current":-1.808479,"twenty":-11.239552,"median":-7.477251,"eighty":-3.665858,"marketCap":338122270},{"date":"2022-11-11","current":-1.973997,"twenty":-11.231385,"median":-7.448202,"eighty":-3.589422,"marketCap":327730806},{"date":"2022-11-18","current":-1.887333,"twenty":-11.222682,"median":-7.42236,"eighty":-3.46397,"marketCap":313342624},{"date":"2022-11-25","current":-1.728451,"twenty":-11.200124,"median":-7.366779,"eighty":-3.315383,"marketCap":286964291},{"date":"2022-12-02","current":-1.742895,"twenty":-11.193244,"median":-7.345635,"eighty":-3.187973,"marketCap":289362321},{"date":"2022-12-09","current":-1.492534,"twenty":-11.176045,"median":-7.291334,"eighty":-3.134618,"marketCap":247796463},{"date":"2022-12-16","current":-1.564753,"twenty":-11.170878,"median":-7.255058,"eighty":-3.093515,"marketCap":259786614},{"date":"2022-12-23","current":-1.694748,"twenty":-11.160897,"median":-7.17358,"eighty":-3.058093,"marketCap":281368887},{"date":"2022-12-30","current":-1.848816,"twenty":-11.116799,"median":-7.102928,"eighty":-3.00812,"marketCap":306947877},{"date":"2023-01-06","current":-1.709192,"twenty":-11.103478,"median":-7.054747,"eighty":-2.977803,"marketCap":283766917},{"date":"2023-01-13","current":-2.407313,"twenty":-11.09068,"median":-7.013799,"eighty":-2.914951,"marketCap":399671715},{"date":"2023-01-20","current":-2.262874,"twenty":-11.070766,"median":-6.968379,"eighty":-2.901449,"marketCap":375691412},{"date":"2023-01-27","current":-2.431386,"twenty":-11.048053,"median":-6.93989,"eighty":-2.850284,"marketCap":403668432},{"date":"2023-02-03","current":-2.248921,"twenty":-11.041891,"median":-6.907359,"eighty":-2.831392,"marketCap":373374900},{"date":"2023-02-10","current":-2.137204,"twenty":-11.040337,"median":-6.853562,"eighty":-2.793261,"marketCap":354827118},{"date":"2023-02-17","current":-2.112917,"twenty":-11.037541,"median":-6.82206,"eighty":-2.774717,"marketCap":350794992},{"date":"2023-02-24","current":-1.942913,"twenty":-11.036477,"median":-6.802631,"eighty":-2.759761,"marketCap":322570108},{"date":"2023-03-03","current":-1.625273,"twenty":-11.030196,"median":-6.790993,"eighty":-2.711745,"marketCap":253217534},{"date":"2023-03-10","current":-1.420669,"twenty":-11.009222,"median":-6.773118,"eighty":-2.662154,"marketCap":221340216},{"date":"2023-03-17","current":-1.161423,"twenty":-11.000648,"median":-6.710401,"eighty":-2.626851,"marketCap":180949666},{"date":"2023-03-24","current":-0.995505,"twenty":-10.988916,"median":-6.70308,"eighty":-2.577952,"marketCap":155099713},{"date":"2023-03-31","current":-1.01106,"twenty":-10.962077,"median":-6.692438,"eighty":-2.500092,"marketCap":157523146},{"date":"2023-04-06","current":-1.062909,"twenty":-10.931816,"median":-6.657557,"eighty":-2.436957,"marketCap":165601257},{"date":"2023-04-14","current":-1.223642,"twenty":-10.921497,"median":-6.636713,"eighty":-2.398479,"marketCap":190643398},{"date":"2023-04-21","current":-1.156238,"twenty":-10.914296,"median":-6.554322,"eighty":-2.368796,"marketCap":180141855},{"date":"2023-04-28","current":-1.005875,"twenty":-10.904834,"median":-6.5307,"eighty":-2.325798,"marketCap":156715335},{"date":"2023-05-05","current":-1.005875,"twenty":-10.88536,"median":-6.511651,"eighty":-2.272503,"marketCap":156715335},{"date":"2023-05-12","current":-0.980447,"twenty":-10.869899,"median":-6.486328,"eighty":-2.248921,"marketCap":194682453},{"date":"2023-05-19","current":-1.053675,"twenty":-10.869899,"median":-6.450763,"eighty":-2.200348,"marketCap":209223051},{"date":"2023-05-26","current":-0.939765,"twenty":-10.862668,"median":-6.413105,"eighty":-2.159059,"marketCap":186604343},{"date":"2023-06-02","current":-0.968242,"twenty":-10.860198,"median":-6.392361,"eighty":-2.148819,"marketCap":192259020},{"date":"2023-06-09","current":-1.017061,"twenty":-10.859458,"median":-6.347111,"eighty":-2.134413,"marketCap":201952752},{"date":"2023-06-16","current":-0.939765,"twenty":-10.853773,"median":-6.33378,"eighty":-2.098346,"marketCap":186604343},{"date":"2023-06-23","current":-0.870604,"twenty":-10.841269,"median":-6.306322,"eighty":-2.090211,"marketCap":172871556},{"date":"2023-06-30","current":-0.878741,"twenty":-10.831773,"median":-6.301447,"eighty":-2.062435,"marketCap":174487178},{"date":"2023-07-07","current":-0.8584,"twenty":-10.828621,"median":-6.247355,"eighty":-2.059487,"marketCap":170448123},{"date":"2023-07-14","current":-0.630578,"twenty":-10.818557,"median":-6.223946,"eighty":-2.035073,"marketCap":125210706},{"date":"2023-07-21","current":-0.610237,"twenty":-10.814044,"median":-6.202589,"eighty":-2.002884,"marketCap":121171651},{"date":"2023-07-28","current":-0.504462,"twenty":-10.811422,"median":-6.177771,"eighty":-1.988044,"marketCap":100168565},{"date":"2023-08-04","current":-0.606168,"twenty":-10.808333,"median":-6.162927,"eighty":-1.965383,"marketCap":120363840},{"date":"2023-08-11","current":-0.717329,"twenty":-10.788727,"median":-6.115637,"eighty":-1.932105,"marketCap":130057572},{"date":"2023-08-18","current":-0.619309,"twenty":-10.777949,"median":-6.098857,"eighty":-1.908523,"marketCap":112285730},{"date":"2023-08-25","current":-0.614854,"twenty":-10.739473,"median":-6.068347,"eighty":-1.867341,"marketCap":111477919},{"date":"2023-09-01","current":-0.534656,"twenty":-10.727364,"median":-6.007328,"eighty":-1.832253,"marketCap":96937321},{"date":"2023-09-08","current":-0.485645,"twenty":-10.725115,"median":-5.944784,"eighty":-1.81759,"marketCap":88051400},{"date":"2023-09-15","current":-0.388962,"twenty":-10.721176,"median":-5.839526,"eighty":-1.773708,"marketCap":70521901},{"date":"2023-09-22","current":-0.324803,"twenty":-10.712425,"median":-5.305609,"eighty":-1.751033,"marketCap":58889422},{"date":"2023-09-29","current":-0.369803,"twenty":-10.702405,"median":-5.16679,"eighty":-1.729414,"marketCap":67048313},{"date":"2023-10-06","current":-0.38317,"twenty":-10.697346,"median":-5.107297,"eighty":-1.694748,"marketCap":69471746},{"date":"2023-10-13","current":-0.373145,"twenty":-10.694467,"median":-5.05238,"eighty":-1.67549,"marketCap":67654172},{"date":"2023-10-20","current":-0.345744,"twenty":-10.694104,"median":-5.001468,"eighty":-1.636973,"marketCap":62686134},{"date":"2023-10-27","current":-0.291788,"twenty":-10.681866,"median":-4.994411,"eighty":-1.626101,"marketCap":52903543},{"date":"2023-11-03","current":-0.311927,"twenty":-10.661649,"median":-4.952046,"eighty":-1.553198,"marketCap":56554848},{"date":"2023-11-10","current":-0.211833,"twenty":-10.658129,"median":-4.93535,"eighty":-1.49579,"marketCap":37813633},{"date":"2023-11-17","current":-0.287769,"twenty":-10.652738,"median":-4.919922,"eighty":-1.466535,"marketCap":51368702},{"date":"2023-11-24","current":-0.33352,"twenty":-10.64287,"median":-4.910192,"eighty":-1.446594,"marketCap":59535671},{"date":"2023-12-01","current":-0.375606,"twenty":-10.630908,"median":-4.885262,"eighty":-1.31697,"marketCap":67048313},{"date":"2023-12-08","current":-0.484215,"twenty":-10.549994,"median":-4.844915,"eighty":-1.223642,"marketCap":86435778},{"date":"2023-12-13","current":-0.466114,"twenty":-10.54793,"median":-4.838513,"eighty":-1.195643,"marketCap":83204534},{"date":"2023-12-20","current":-0.610926,"twenty":-10.546554,"median":-4.831835,"eighty":-1.192532,"marketCap":109054486},{"date":"2023-12-29","current":-0.719535,"twenty":-10.54425,"median":-4.805252,"eighty":-1.158312,"marketCap":128441950},{"date":"2024-01-05","current":-0.85077,"twenty":-10.540793,"median":-4.794574,"eighty":-1.119943,"marketCap":151868469},{"date":"2024-01-12","current":-0.936753,"twenty":-10.508716,"median":-4.768224,"eighty":-1.078085,"marketCap":167216879},{"date":"2024-01-19","current":-0.828144,"twenty":-10.486701,"median":-4.761711,"eighty":-1.062909,"marketCap":147829414},{"date":"2024-01-26","current":-1.172072,"twenty":-10.459619,"median":-4.750335,"eighty":-1.05774,"marketCap":209223051},{"date":"2024-02-02","current":-1.629135,"twenty":-10.445532,"median":-4.728978,"eighty":-1.061876,"marketCap":290811963},{"date":"2024-02-09","current":-1.778472,"twenty":-10.443278,"median":-4.692209,"eighty":-1.062909,"marketCap":317469726},{"date":"2024-02-16","current":-2.249111,"twenty":-10.432331,"median":-4.678231,"eighty":-1.062909,"marketCap":401482071},{"date":"2024-02-23","current":-2.212908,"twenty":-10.428728,"median":-4.671459,"eighty":-1.06602,"marketCap":395019583},{"date":"2024-03-01","current":-2.185756,"twenty":-10.428023,"median":-4.654836,"eighty":-1.071205,"marketCap":390172717},{"date":"2024-03-08","current":-2.249111,"twenty":-10.424808,"median":-4.63745,"eighty":-1.076163,"marketCap":401482071},{"date":"2024-03-15","current":-1.285802,"twenty":-10.422173,"median":-4.564227,"eighty":-1.078085,"marketCap":308660513},{"date":"2024-03-22","current":-1.584905,"twenty":-10.418227,"median":-4.534645,"eighty":-1.080526,"marketCap":380461220},{"date":"2024-03-28","current":-1.443948,"twenty":-10.414553,"median":-4.517949,"eighty":-1.084825,"marketCap":346624105},{"date":"2024-04-05","current":-1.619285,"twenty":-10.41109,"median":-4.460118,"eighty":-1.101278,"marketCap":388714175},{"date":"2024-04-12","current":-1.608971,"twenty":-10.405728,"median":-4.414434,"eighty":-1.124091,"marketCap":386238289},{"date":"2024-04-19","current":-1.636475,"twenty":-10.398069,"median":-4.295892,"eighty":-1.140683,"marketCap":392840653},{"date":"2024-04-26","current":-1.52646,"twenty":-10.377654,"median":-4.22076,"eighty":-1.158312,"marketCap":366431197},{"date":"2024-05-03","current":-1.631766,"twenty":-10.352893,"median":-4.075824,"eighty":-1.165683,"marketCap":391710220},{"date":"2024-05-10","current":-1.934067,"twenty":-10.348284,"median":-3.980337,"eighty":-1.180256,"marketCap":439584360},{"date":"2024-05-17","current":-1.730926,"twenty":-10.340625,"median":-3.906874,"eighty":-1.192532,"marketCap":393413574},{"date":"2024-05-24","current":-1.541071,"twenty":-10.334498,"median":-3.812485,"eighty":-1.194606,"marketCap":350262319},{"date":"2024-05-31","current":-1.456397,"twenty":-10.330668,"median":-3.709778,"eighty":-1.199791,"marketCap":331017137},{"date":"2024-06-07","current":-1.473332,"twenty":-10.31535,"median":-3.648185,"eighty":-1.208125,"marketCap":334866173},{"date":"2024-06-14","current":-1.337853,"twenty":-10.278586,"median":-3.606118,"eighty":-1.208275,"marketCap":304073881},{"date":"2024-06-21","current":-1.138868,"twenty":-10.272811,"median":-3.552032,"eighty":-1.196955,"marketCap":258847703},{"date":"2024-06-28","current":-1.189673,"twenty":-10.269747,"median":-3.518578,"eighty":-1.194669,"marketCap":270394812},{"date":"2024-07-05","current":-1.295516,"twenty":-10.263268,"median":-3.471164,"eighty":-1.197717,"marketCap":294451290},{"date":"2024-07-12","current":-1.604577,"twenty":-10.255609,"median":-3.335924,"eighty":-1.208087,"marketCap":364696206},{"date":"2024-07-15","current":-1.617278,"twenty":-10.254843,"median":-3.325654,"eighty":-1.208125,"marketCap":367582983},{"date":"2024-08-02","current":-1.295516,"twenty":-10.254077,"median":-3.315383,"eighty":-1.208162,"marketCap":294451290},{"date":"2024-08-09","current":-1.263706,"twenty":-10.233994,"median":-3.270494,"eighty":-1.210995,"marketCap":271579334},{"date":"2024-08-16","current":-1.317672,"twenty":-10.192933,"median":-3.17981,"eighty":-1.208162,"marketCap":283177028},{"date":"2024-08-23","current":-1.268203,"twenty":-10.162167,"median":-3.145552,"eighty":-1.210995,"marketCap":272545809},{"date":"2024-08-30","current":-1.290689,"twenty":-10.138739,"median":-3.105322,"eighty":-1.216769,"marketCap":277378181},{"date":"2024-09-06","current":-1.272701,"twenty":-10.12297,"median":-3.093515,"eighty":-1.220176,"marketCap":273512283},{"date":"2024-09-13","current":-1.32217,"twenty":-10.116822,"median":-3.065371,"eighty":-1.220176,"marketCap":284143503},{"date":"2024-09-20","current":-1.443593,"twenty":-10.112524,"median":-3.046286,"eighty":-1.224459,"marketCap":310238314},{"date":"2024-09-27","current":-1.349715,"twenty":-10.110085,"median":-3.003246,"eighty":-1.228628,"marketCap":290063127},{"date":"2024-10-04","current":-1.37221,"twenty":-10.110085,"median":-2.991185,"eighty":-1.247882,"marketCap":294897512},{"date":"2024-10-11","current":-1.232739,"twenty":-10.108988,"median":-2.979377,"eighty":-1.25472,"marketCap":264924322},{"date":"2024-10-18","current":-1.412701,"twenty":-10.098738,"median":-2.942483,"eighty":-1.256542,"marketCap":303599406},{"date":"2024-10-25","current":-1.300225,"twenty":-10.072544,"median":-2.912771,"eighty":-1.264605,"marketCap":279427479},{"date":"2024-10-31","current":-1.327219,"twenty":-10.061536,"median":-2.908534,"eighty":-1.268203,"marketCap":285228741},{"date":"2024-11-08","current":-1.342191,"twenty":-10.016819,"median":-2.877047,"eighty":-1.272701,"marketCap":283294987},{"date":"2024-11-15","current":-1.207766,"twenty":-10.002857,"median":-2.845561,"eighty":-1.272701,"marketCap":256227485},{"date":"2024-11-22","current":-0.884176,"twenty":-9.999027,"median":-2.833754,"eighty":-1.254712,"marketCap":187577856},{"date":"2024-11-29","current":-1.102941,"twenty":-9.922436,"median":-2.823914,"eighty":-1.235926,"marketCap":233988873},{"date":"2024-12-06","current":-0.87506,"twenty":-9.878778,"median":-2.801848,"eighty":-1.222775,"marketCap":185644064},{"date":"2024-12-13","current":-0.902406,"twenty":-9.842136,"median":-2.782034,"eighty":-1.218462,"marketCap":191445441},{"date":"2024-12-20","current":-0.966213,"twenty":-9.834385,"median":-2.774717,"eighty":-1.208023,"marketCap":204981988},{"date":"2024-12-27","current":-0.966213,"twenty":-9.830318,"median":-2.76291,"eighty":-1.195312,"marketCap":204981988},{"date":"2025-01-03","current":-0.911521,"twenty":-9.816532,"median":-2.755039,"eighty":-1.190817,"marketCap":193379234},{"date":"2025-01-10","current":-0.87506,"twenty":-9.799245,"median":-2.727488,"eighty":-1.162092,"marketCap":185644064},{"date":"2025-01-17","current":-0.797581,"twenty":-9.795781,"median":-2.68813,"eighty":-1.132024,"marketCap":169206829},{"date":"2025-01-24","current":-0.802139,"twenty":-9.79223,"median":-2.664516,"eighty":-1.102941,"marketCap":170173725},{"date":"2025-01-31","current":-0.783908,"twenty":-9.753934,"median":-2.6379,"eighty":-1.078085,"marketCap":166306141},{"date":"2025-02-07","current":-0.738332,"twenty":-9.750105,"median":-2.624564,"eighty":-1.062909,"marketCap":156637179},{"date":"2025-02-14","current":-0.733775,"twenty":-9.727127,"median":-2.578044,"eighty":-1.057724,"marketCap":155670283},{"date":"2025-02-21","current":-0.76112,"twenty":-9.722219,"median":-2.565218,"eighty":-1.046317,"marketCap":161471660},{"date":"2025-02-28","current":-0.720102,"twenty":-9.701391,"median":-2.501409,"eighty":-1.037402,"marketCap":152769594},{"date":"2025-03-07","current":-0.797581,"twenty":-9.675045,"median":-2.460274,"eighty":-1.026615,"marketCap":169206829},{"date":"2025-03-14","current":-0.806696,"twenty":-9.663556,"median":-2.41935,"eighty":-1.016898,"marketCap":171140622},{"date":"2025-03-21","current":-0.774793,"twenty":-9.609408,"median":-2.398479,"eighty":-1.016245,"marketCap":164372348},{"date":"2025-03-28","current":-0.954142,"twenty":-9.587597,"median":-2.385077,"eighty":-1.011643,"marketCap":150607433},{"date":"2025-04-04","current":-0.772101,"twenty":-9.576242,"median":-2.368796,"eighty":-1.005875,"marketCap":121873120},{"date":"2025-04-11","current":-0.703052,"twenty":-9.567817,"median":-2.338996,"eighty":-0.992186,"marketCap":110973898},{"date":"2025-04-17","current":-0.728161,"twenty":-9.535072,"median":-2.32592,"eighty":-0.985973,"marketCap":114937252}],"updateTime":1745272167185}}}